4.7 Article Proceedings Paper

α7 receptor-selective agonists and modes of α7 receptor activation

期刊

EUROPEAN JOURNAL OF PHARMACOLOGY
卷 393, 期 1-3, 页码 179-195

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/S0014-2999(00)00009-1

关键词

GTS-21; 40H-GTS-21; alpha 7 receptor-selective agonist

资金

  1. NINDS NIH HHS [NS32888-02] Funding Source: Medline

向作者/读者索取更多资源

The alpha 7-selective agonists 3-(2,4-dimethoxybenzylidene)-anabaseine (GTS-21), also known as DMXB, and 3-(4-hydroxy,2-methoxybenzylidene)anabaseine (4OH-GTS-21) produce a variety of behavioral and cytoprotective effects that may be related to the activation of either large transient currents at high concentrations or small sustained currents at lower agonist concentrations. We are using acutely dissociated hypothalamic neurons, which express a central nervous system (CNS) alpha 7-type receptor, to test a model for the concentration-dependent desensitization of alpha 7-mediated responses. Our results confirm that 40H-GTS-21 is a potent activator of neuronal alpha 7 nicotinic-acetylcholine receptor. The rapid application of agonist leads to a brief period of maximal receptor-activation followed by desensitization. Rise rates, decay rates, and the degree to which current was desensitized were all concentration-dependent. Following the initial peak response to a 300-mu M 4OH-GTS-21 application, current is reduced to baseline values within about 100 ms. Application of 30 mu M 40H-GTS-21 produced both a transient peak current and a sustained current that decayed only slowly after the removal of agonist. In the case of a 300-mu M 40H-GTS-21 application, after agonist was removed, we saw a rebound response up to the level of the 30-mu M sustained current. The data, therefore, suggest that a sufficient level of agonist occupation can be retained on the receptor to promote activation for up to several hundred milliseconds. (C) 2000 Elsevier Science B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据